Botulinum toxin type A injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response

A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome

(2013) Jane Manning et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Persistent Therapeutic Effect of Repeated Injections of Onabotulinum Toxin A in Refractory Bladder Pain Syndrome/Interstitial Cystitis

(2012) Rui Pinto et al.   JOURNAL OF UROLOGY

Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome

(2010) Jia-Heng Shie et al.   BJU INTERNATIONAL

Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome/interstitial cystitis: a systematic review

(2010) Sahithi Tirumuru et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment

(2009) Hsin-Tzu Liu et al.   BJU INTERNATIONAL

Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome

(2009) Hann-Chorng Kuo et al.   BJU INTERNATIONAL

Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome

(2009) Yukio Homma et al.   INTERNATIONAL JOURNAL OF UROLOGY

Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup

(2008) Antonella Giannantoni et al.   JOURNAL OF UROLOGY

Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review

(2007) Gilles Karsenty et al.   EUROPEAN UROLOGY